Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomyMeera R. Chappidi, Trinity J. Bivalacqua, Deborah R. Kaye et al.|Urologic Oncology Seminars and Original Investigations|2016Cited by 130
Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder CancerNiv Milbar, Trinity J. Bivalacqua, Max Kates et al.|Bladder Cancer|2017Cited by 86
Causes, Timing, Hospital Costs and Perioperative Outcomes of Index vs Nonindex Hospital Readmissions after Radical Cystectomy: Implications for Regionalization of CareMeera R. Chappidi, Trinity J. Bivalacqua, Max Kates et al.|The Journal of Urology|2016Cited by 52
Quantifying Nonindex Hospital Readmissions and Care Fragmentation after Major Urological Oncology Surgeries in a Nationally Representative SampleMeera R. Chappidi, Phillip M. Pierorazio, Max Kates et al.|The Journal of Urology|2016Cited by 42
Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population–based analysis (2004–2012)Meera R. Chappidi, Phillip M. Pierorazio, Noah M. Hahn et al.|Urologic Oncology Seminars and Original Investigations|2016Cited by 35